0001437749-24-017053.txt : 20240515
0001437749-24-017053.hdr.sgml : 20240515
20240515161134
ACCESSION NUMBER: 0001437749-24-017053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240513
FILED AS OF DATE: 20240515
DATE AS OF CHANGE: 20240515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LeMaitre George W
CENTRAL INDEX KEY: 0001365737
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 24950765
MAIL ADDRESS:
STREET 1: 342 BUNKER HILL STREET, #2B
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-05-13
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365737
LeMaitre George W
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
1
Chairman and CEO
1
Common Stock
2024-05-13
4
S
0
35826
76.4162
D
2043302
D
Common Stock
2024-05-14
4
G
0
4000
0
D
2039302
D
Common Stock
2024-05-14
4
S
0
40968
76.80070
D
1998334
D
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.24 to $76.60. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
Adoption date of referenced 10b5-1(c) plan is: 06-02-2023
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.60 to $77.07. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
/s/ Nathaniel R.J. Ulrich
2024-05-15